The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Left atrial appendage closure: patient, device and post-procedure drug selection

EuroIntervention 2016;12:X48-X54. DOI: 10.4244/EIJV12SXA10

1. AHEPA University Hospital, Thessaloniki, Greece; 2. Cardiologicum Hamburg, Hamburg, Germany

Left atrial appendage closure (LAAC), a device-based therapy for stroke prevention in patients with atrial fibrillation, is considered an alternative to oral anticoagulation therapy, particularly for patients at high risk of

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Catheter-based treatment of paravalvular leaks